Annual Drug Patent Expirations for IGALMI
Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has sixty-two patent family members in fourteen countries.
The generic ingredient in IGALMI is dexmedetomidine hydrochloride. One supplier is listed for this compound. Additional details are available on the dexmedetomidine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
